LSL Pharma Group Inc. sees a slight uptick in price despite a challenging week.
LSL Pharma Group Inc. (LSL.V) experienced a modest increase of 3.45% in its stock price today, closing at C$0.29. However, the stock has declined by 9.09% over the past week and 10.45% over the last month. With no significant news driving this price movement, investors may be seeking insights into the stock's technical and fundamental conditions.
Advertisement
LSL Pharma Group Inc.
LSL.V
LSL.V
LSL Pharma Group Inc.
WealthAwesomeMarket cap
$38.02M
52W high
$0.56
52W low
$0.29
1W change
-9.09%
Beta
-0.52
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on LSL's historical volatility
30-Day Vol
45.7%
Annualized
90-Day Vol
49.7%
Annualized
Trend (90d)
-20.5%
Annualized drift
90d Mean
C$0.28
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.29 | C$0.25 – C$0.34 |
| 60 trading days | C$0.29 | C$0.23 – C$0.36 |
| 90 trading days | C$0.28 | C$0.21 – C$0.37 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Despite today's positive movement, LSL Pharma Group's ongoing struggles in the market, reflected in its year-to-date decline and negative profit margins, warrant cautious consideration for potential investors.
C$0.29 - Current Stock Price
The stock is currently at the lower end of its 52-week range, indicating potential undervaluation, but also reflecting the company's ongoing challenges.
Bull case
Investors might see potential in LSL Pharma Group if the company can stabilize its operations and improve its margins. This could lead to a recovery in its stock price.
Bear case
The significant year-to-date decline and negative financial metrics suggest ongoing challenges for LSL Pharma Group, indicating potential risks for investors considering entry points.
Price Action Overview
Advertisement
LSL Pharma Group Inc. (LSL.V) closed at C$0.29 today, reflecting a 3.45% increase. Despite this uptick, the stock has faced a challenging week with a 9.09% decline. Over the past month, the stock is down 10.45%, and year-to-date, it has dropped 14.29%. The latest trading volume was 30,000 shares, which is 1.23 times the 20-day average volume of 21,331 shares.
Technical Picture
From a technical perspective, LSL Pharma Group's current price of C$0.29 is significantly below its 50-day moving average of C$0.34 and 200-day moving average of C$0.38, indicating a bearish trend. The stock has a 52-week range of C$0.29 to C$0.56, currently sitting at the bottom of this range. With a beta of -0.52, the stock has shown less volatility compared to the broader market.
Fundamental Analysis
LSL Pharma Group has a market capitalization of approximately C$38 million. The company is currently operating at a loss, with a profit margin of -17.5% and return on equity (ROE) of -31.6%. The trailing twelve months (TTM) earnings per share (EPS) stands at -C$0.06, reflecting ongoing financial challenges that may concern potential investors.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
